BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 26381261)

  • 1. Performance of principal scores to estimate the marginal compliers causal effect of an intervention.
    Porcher R; Leyrat C; Baron G; Giraudeau B; Boutron I
    Stat Med; 2016 Feb; 35(5):752-67. PubMed ID: 26381261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the use of propensity scores in principal causal effect estimation.
    Jo B; Stuart EA
    Stat Med; 2009 Oct; 28(23):2857-75. PubMed ID: 19610131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-stage instrumental variable methods for estimating the causal odds ratio: analysis of bias.
    Cai B; Small DS; Have TR
    Stat Med; 2011 Jul; 30(15):1809-24. PubMed ID: 21495062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The performance of different propensity score methods for estimating marginal odds ratios.
    Austin PC
    Stat Med; 2007 Jul; 26(16):3078-94. PubMed ID: 17187347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation and inference for the causal effect of receiving treatment on a multinomial outcome.
    Cheng J
    Biometrics; 2009 Mar; 65(1):96-103. PubMed ID: 18373714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simple efficient bias corrected instrumental variable estimator for randomized trials with noncompliance.
    Chan KC
    Contemp Clin Trials; 2012 Jul; 33(4):786-93. PubMed ID: 22484340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Marginal mean weighting through stratification: a generalized method for evaluating multivalued and multiple treatments with nonexperimental data.
    Hong G
    Psychol Methods; 2012 Mar; 17(1):44-60. PubMed ID: 21843003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditioning on the propensity score can result in biased estimation of common measures of treatment effect: a Monte Carlo study.
    Austin PC; Grootendorst P; Normand SL; Anderson GM
    Stat Med; 2007 Feb; 26(4):754-68. PubMed ID: 16783757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The performance of different propensity-score methods for estimating relative risks.
    Austin PC
    J Clin Epidemiol; 2008 Jun; 61(6):537-45. PubMed ID: 18471657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Causal mediation analysis with multiple mediators in the presence of treatment noncompliance.
    Park S; Kürüm E
    Stat Med; 2018 May; 37(11):1810-1829. PubMed ID: 29542166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Model misspecification and robustness in causal inference: comparing matching with doubly robust estimation.
    Waernbaum I
    Stat Med; 2012 Jul; 31(15):1572-81. PubMed ID: 22359267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bias analysis of the instrumental variable estimator as an estimator of the average causal effect.
    Chiba Y
    Contemp Clin Trials; 2010 Jan; 31(1):12-7. PubMed ID: 19879376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating causal effects from a randomized clinical trial when noncompliance is measured with error.
    Boatman JA; Vock DM; Koopmeiners JS; Donny EC
    Biostatistics; 2018 Jan; 19(1):103-118. PubMed ID: 28605411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Principal stratification with predictors of compliance for randomized trials with 2 active treatments.
    Roy J; Hogan JW; Marcus BH
    Biostatistics; 2008 Apr; 9(2):277-89. PubMed ID: 17681993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessing the sensitivity of methods for estimating principal causal effects.
    Stuart EA; Jo B
    Stat Methods Med Res; 2015 Dec; 24(6):657-74. PubMed ID: 21971481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A causal model for longitudinal randomised trials with time-dependent non-compliance.
    Becque T; White IR; Haggard M
    Stat Med; 2015 May; 34(12):2019-34. PubMed ID: 25778798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sensitivity analysis for principal ignorability violation in estimating complier and noncomplier average causal effects.
    Nguyen TQ; Stuart EA; Scharfstein DO; Ogburn EL
    Stat Med; 2024 Jun; ():. PubMed ID: 38890728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Model misspecification sensitivity analysis in estimating causal effects of interventions with non-compliance.
    Jo B
    Stat Med; 2002 Nov; 21(21):3161-81. PubMed ID: 12375297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A principal stratification approach for evaluating natural direct and indirect effects in the presence of treatment-induced intermediate confounding.
    Taguri M; Chiba Y
    Stat Med; 2015 Jan; 34(1):131-44. PubMed ID: 25312003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Causal models for randomized trials with two active treatments and continuous compliance.
    Ma Y; Roy J; Marcus B
    Stat Med; 2011 Aug; 30(19):2349-62. PubMed ID: 21751229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.